Extracellular Mitochondria Mediate Endothelial Injury After Traumatic Brain Injury
BACKGROUND: Local and systemic endothelial dysfunction following traumatic brain injury (TBI) results in secondary cerebral and pulmonary edema, tissue ischemia, and inflammation. However, the underlying mechanism of the endothelial dysfunction beyond the site of the primary trauma remains poorly understood. Morphologically intact and metabolically active extracellular mitochondria (exMt) accounted for 55.2% of brain-derived extracellular vesicles found in the peripheral blood of mice subjected to severe TBI. This observation led us to investigate the role of exMt in TBI-induced secondary endothelial injury. METHODS: We measured circulating exMt in patients with TBI and mice subjected to TBI and examined the effects of exMt on endothelial cells in vitro and in vivo. Mechanistic studies involved evaluating Cavin-1-dependent endocytosis of exMt and its downstream effects on endothelial cells, including mitophagy activation, lysosomal dysfunction, and apoptosis. The findings were validated in Cavin-1 knockdown endothelial cells and Cavin-1-deficient mice. RESULTS: Here, we report the detection of high levels of exMt in the peripheral blood samples from patients with TBI. These circulating exMt bound to and were endocytosed by endothelial cells via a Cavin-1-dependent pathway. exMt activated endothelial cells, caused vascular leakage, and promoted an inflammatory response in vitro. Furthermore, noninjured mice infused with exMt developed similar changes in the brain and lungs. exMt endocytosed by endothelial cells activated mitophagy and promoted the formation of mitophagosomes but impaired lysosomal function, leading to endothelial cell apoptosis. CONCLUSIONS: Results from this study demonstrate a novel subcellular mechanism for exMt-induced endothelial dysfunction during acute TBI.
Authors
- Xiaoxi Lu (ORCID: https://orcid.org/0000-0002-5494-589X)
- Ying Fu (ORCID: https://orcid.org/0000-0002-1590-3945)
- Yafan Liu (ORCID: https://orcid.org/0000-0002-4200-0098)
- Jing‐fei Dong (ORCID: https://orcid.org/0000-0001-6379-4133)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-2358-0904)
- Tianrui Ma (ORCID: https://orcid.org/0000-0003-0894-6653)
- Haitao Zhang (ORCID: https://orcid.org/0000-0002-1639-4089)
- Zilong Zhao (ORCID: https://orcid.org/0000-0001-8218-6395)
- Jianning Zhang (ORCID: https://orcid.org/0000-0002-6733-8511)
- J.J. Liu
- Lujia Tang
- Pengbo Zhao
- Zijian Zhou
- Xiaoyang Zhang
- Ming Wei
- Yang Li
- Kaifeng Pang
Institutions
- Fujian Medical University (CN)
- Zunyi Medical University (CN)
- University of Washington (US)
- Sichuan University (CN)
- Kunming Medical University (CN)
- Second Affiliated Hospital of Kunming Medical College (CN)
- Bloodworks Northwest (US)
- Tianjin Medical University General Hospital (CN)
- Tianjin Huanhu Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1161/atvbaha.126.323502
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00